(PharmaNewsWire.Com, October 27, 2017 ) Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global and United States Amifostine Market Report 2017”, report studies the Amifostine market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Amifostine market by product type and applications/end industries.
Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.
Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Amifostine in these regions, from 2012 to 2023 (forecast), covering United States North America Europe Asia-Pacific South America
The major players in global and United States Amifostine market, including Clinigen Group Sun Pharmaceutical Taj Pharmaceuticals Merro Pharmaceutical Luye Pharma Mingren Pharma
On the basis of product, the Amifostine market is primarily split into 400mg/Dose 500mg/Dose On the basis on the end users/applications, this report covers
Ovarian Cancer Adjuvant Therapy Head and Neck Cancer Adjuvant Therapy Others
Table of Content: 1 Amifostine Market Overview1 1.1 Amifostine Product Overview1 1.2 Global Amifostine Product Segment by Type3 1.2.1 Global Amifostine Sales (K Unit) and Growth (%) by Types (2012, 2016 and 2023)3 1.2.2 Global Amifostine Sales (K Unit) and Market Share (%) by Types (2012-2017)4 1.2.3 Global Amifostine Revenue (Million USD) and Market Share (%) by Types (2012-2017)4 1.2.4 Global Amifostine Price (USD/Unit) by Type (2012-2017)5 1.3 United States Amifostine Product Segment by Type6 1.3.1 United States Amifostine Sales (K Unit) and Growth by Types (2012, 2016 and 2023)6 1.3.2 United States Amifostine Sales (K Unit) and Market Share by Types (2012-2017)6 1.3.3 United States Amifostine Revenue (Million USD) and Market Share by Types (2012-2017)6 1.3.4 United States Amifostine Price (USD/Unit) by Type (2012-2017)7 2 Amifostine Application/End Users8 2.1 Amifostine Segment by Application/End Users8 2.2 Global Amifostine Product Segment by Application8 2.2.1 Global Amifostine Sales (K Unit) and CGAR (%) by Applications (2012, 2016 and 2023)8 2.2.2 Global Amifostine Sales (K Unit) and Market Share (%) by Applications (2012-2017)8 2.3 United States Amifostine Product Segment by Application9 2.3.1 United States Amifostine Sales (K Unit) and CGAR (%) by Applications (2012, 2016 and 2023)9 2.3.2 United States Amifostine Sales (K Unit) and Market Share (%) by Applications (2012-2017)10 3 Amifostine Market Status and Outlook by Regions12 3.1 Global Market Status and Outlook by Regions12 3.1.1 Global Amifostine Market Size and CAGR by Regions (2012, 2016 and 2023)12 3.1.2 North America12 3.1.3 Asia-Pacific13 3.1.4 Europe14 3.1.5 South America15 3.1.6 United States16 3.2 Global Amifostine Sales and Revenue by Regions17 3.2.1 Global Amifostine Sales (K Unit) and Market Share (%) by Regions (2012-2017)17 3.2.2 Global Amifostine Revenue (Million USD) and Market Share (%) by Regions (2012-2017)19 3.2.3 Global Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)21 3.2.4 North America Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)22 3.2.5 Europe Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)22 3.2.6 Asia-Pacific Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)23 3.2.7 South America Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)23 3.2.8 United States Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)24 4 Global Amifostine Market Competition by Players/Manufacturers25 4.1 Global Amifostine Sales (K Unit) and Market Share by Players (2012-2017)25 4.2 Global Amifostine Revenue (Million USD) and Share by Players (2012-2017)27 4.3 Global Amifostine Average Price (USD/Unit) by Players (2012-2017)29 4.4 Global Top Players Amifostine Manufacturing Base Distribution, Sales Area30 4.5 Amifostine Market Competitive Situation and Trends31 4.5.1 Amifostine Market Concentration Rate31 4.5.2 Global Amifostine Market Share (%) of Top 3 and Top 5 Players32 4.5.3 Mergers & Acquisitions, Expansion33 5 United States Amifostine Market Competition by Players/Manufacturers34 5.1 United States Amifostine Sales (K Unit) and Market Share by Players (2012-2017)34 5.2 United States Amifostine Revenue (Million USD) and Share by Players (2012-2017)36 5.3 United States Amifostine Average Price (USD/Unit) by Players (2012-2017)37 6 Amifostine Players/Manufacturers Profiles and Sales Data38 6.1 Clinigen Group38 6.1.1 Company Basic Information, Manufacturing Base and Competitors38 6.1.2 Amifostine Product Category and Specification39 6.1.3 Clinigen Group Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)39 6.1.4 Main Business/Business Overview41 6.2 Sun Pharmaceutical41 6.2.1 Company Basic Information, Manufacturing Base and Competitors41 6.2.2 Amifostine Product Picture42 6.2.3 Sun Pharmaceutical Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)42 6.2.4 Main Business/Business Overview44 6.3 Taj Pharmaceuticals44 6.3.1 Company Basic Information, Manufacturing Base and Competitors44 6.3.2 Amifostine Product Category and Specification45 6.3.3 Taj Pharmaceuticals Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)45 6.3.4 Main Business/Business Overview47 6.4 Merro Pharmaceutical47 6.4.1 Company Basic Information, Manufacturing Base and Competitors47 6.4.2 Amifostine Product Category and Specification49 6.4.3 Merro Pharmaceutical Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)49 6.4.4 Main Business/Business Overview51 6.5 Luye Pharma51 6.5.1 Company Basic Information, Manufacturing Base and Competitors51 6.5.2 Amifostine Product Picture52 6.5.3 Luye Pharma Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)53 6.5.4 Main Business/Business Overview54 6.6 Mingren Pharma54 6.6.1 Company Basic Information, Manufacturing Base and Competitors54 6.6.2 Amifostine Product Picture55 6.6.3 Mingren Pharma Amifostine Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)56 6.6.4 Main Business/Business Overview Continue….
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps. MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
